Ultraflex™ Esophageal NG M00513710Recalls & reported problems
Boston Scientific Corporation · Distal Release Stent System · Class 2 · Implant
All models of Ultraflex Esophageal NG (15)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729716136), received between Aug 20, 2021 and Jul 24, 2025 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Activation, Positioning or Separation Problem2
- Adverse Event Without Identified Device or Use Problem1
- Break1
- Material Deformation1
- Migration1
- Unraveled Material1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Pneumonia1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 24, 2025Activation, Positioning or Separation Problem; Adverse Event Without Identified Device or Use Problem; Activation, Positioning or Separation Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ULTRAFLEX ESOPHAGEAL NG STENT WAS TO BE IMPLANTED IN THE MID-ESOPHAGUS TO TREAT ESOPHAGEAL CANCER CAUSING A 4 CENTIMETER STENOSIS DURING AN ESOPHAGEAL STENT PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2025. THE PATIENT'S ANATOMY WAS NOT DILATED PRIOR TO STENT PLACEMENT. DURING THE PROCEDURE, THE STENT FAILED TO BE RELEASED. THE HANDLE COULD NO LONGER BE MOVED PARTWAY THROUGH. A PARTIAL RECAPTURE COULD NOT BE PERFORMED EITHER. A STENT-IN-STENT RELEASE WAS ATTEMPTED; HOWEVER, THE SUTURE WAS TOO STIFF, PREVENTING DEPLOYMENT. THE STENT WAS TEMPORARILY REMOVED FOR EVALUATION, BUT REINSERTION WAS NO LONGER POSSIBLE. THE STENT WAS REMOVED PARTIALLY DEPLOYED FROM THE PATIENT AND THE PROCEDURE WAS COMPLETED WITH ANOTHER SAME MODEL STENT. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22600301 ↗MalfunctionJan 12, 2022Break; Unraveled Material; Activation, Positioning or Separation Problem; Material Deformation; Break; Unraveled Material; Activation, Positioning or Separation Problem; Material Deformation
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ULTRAFLEX ESOPHAGEAL NG DISTAL RELEASE UNCOVERED STENT WAS TO BE IMPLANTED TO TREAT A 6-7 CM MALIGNANT ESOPHAGEAL STRICTURE DURING A PROCEDURE PERFORMED ON (B)(6) 2021. DURING THE PROCEDURE, THE STENT WAS ATTEMPTED TO BE DEPLOYED BUT THE BLACK DEPLOYMENT SUTURE GOT KNOTTED. THE STENT WAS PARTIALLY DEPLOYED ON THE DELIVERY SYSTEM WHEN IT WAS REMOVED FROM THE PATIENT. ANOTHER ULTRAFLEX ESOPHAGEAL STENT WAS IMPLANTED TO COMPLETE THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE END OF THE PROCEDURE WAS REPORTED TO BE STABLE. NOTE: THIS COMPLAINT HAS BEEN DEEMED MDR REPORTABLE BASED ON THE INVESTIGATION RESULT OF STENT DETACHED AND STENT UNRAVELED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13236191 ↗InjuryAug 20, 2021Migration; Migration
BOSTON SCIENTIFIC BECAME AWARE OF AN EVENT INVOLVING AN ULTRAFLEX ESOPHAGEAL NG DISTAL RELEASE UNCOVERED STENT THROUGH THE ARTICLE "CASE STUDY ON AIRWAY STENT PLACEMENT FOR EMERGENCY AIRWAY DUE TO ADVANCED ESOPHAGEAL CANCER" BY DR. MIKA TAKASHIMA, ET AL. ACCORDING TO THE LITERATURE, AN ULTRAFLEX ESOPHAGEAL NG DISTAL RELEASE UNCOVERED STENT WAS IMPLANTED IN THE LEFT MAIN BRONCHUS TO TREAT A RESPIRATORY TRACT STENOSIS DUE TO ADVANCED ESOPHAGEAL CANCER DURING A STENT PLACEMENT PROCEDURE PERFORMED BETWEEN 2019 AND 2020. ON AN UNKNOWN DATE, 1300 DAYS AFTER STENT PLACEMENT, IT WAS NOTED THAT THE STENT GRADUALLY MOVED TO THE CENTRAL SIDE OF THE BRONCHUS. REPORTEDLY, PNEUMONIA WAS OBSERVED DUE TO STUBBORN COUGH AND SPUTUM DISCHARGED DIFFICULTY. THE STENT WAS REMOVED FROM THE PATIENT. NOTE: BOSTON SCIENTIFIC HAS BEEN UNABLE TO OBTAIN ADDITIONAL INFORMATION REGARDING THE EVENT TO DATE, DESPITE GOOD FAITH EFFORTS.
Patient problems: Pneumonia
MAUDE report 12347773 ↗
Other PROSTHESIS, ESOPHAGEAL devices
- WallFlex™ Esophageal M00516730Boston Scientific Corporation · PROSTHESIS, ESOPHAGEAL1 recall29 reports
- WallFlex™ Esophageal M00516740Boston Scientific Corporation · PROSTHESIS, ESOPHAGEAL1 recall1 death22 reports
- WallFlex™ Esophageal M00516750Boston Scientific Corporation · PROSTHESIS, ESOPHAGEAL1 recall1 death19 reports
- WallFlex™ Esophageal M00516700Boston Scientific Corporation · PROSTHESIS, ESOPHAGEAL1 recall18 reports
- WallFlex™ Esophageal M00516910Boston Scientific Corporation · PROSTHESIS, ESOPHAGEAL1 recall15 reports
- WallFlex™ Esophageal M00516930Boston Scientific Corporation · PROSTHESIS, ESOPHAGEAL1 recall14 reports
- WallFlex™ Esophageal M00516710Boston Scientific Corporation · PROSTHESIS, ESOPHAGEAL1 recall13 reports
- WallFlex™ Esophageal M00516940Boston Scientific Corporation · PROSTHESIS, ESOPHAGEAL1 recall12 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page